Key statistics
On Friday, Resmed Inc (RMD:NYQ) closed at 257.92, -1.95% below its 52-week high of 263.05, set on Jan 30, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 258.09 |
---|---|
High | 260.37 |
Low | 256.53 |
Bid | 237.30 |
Offer | 270.00 |
Previous close | 256.42 |
Average volume | 781.23k |
---|---|
Shares outstanding | 146.63m |
Free float | 145.66m |
P/E (TTM) | 28.79 |
Market cap | 37.60bn USD |
EPS (TTM) | 8.91 USD |
Annual div (ADY) | 2.12 USD |
---|---|
Annual div yield (ADY) | 0.83% |
Div ex-date | May 08 2025 |
Div pay-date | Jun 12 2025 |
Data delayed at least 15 minutes, as of Jul 18 2025 21:00 BST.
More ▼
- Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025
- Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025
- Resmed Acquires VirtuOx
- Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025
- Resmed Names Salli Schwartz as Chief Investor Relations Officer
- Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US
- Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025
- New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer
- Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
- ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep
More ▼